Loading clinical trials...
Loading clinical trials...
A Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of MK-4082 in Healthy Overweight/Obese Participants
Conditions
Interventions
MK-4082
Placebo
Locations
5
United States
Anaheim Clinical Trials ( Site 0005)
Anaheim, California, United States
ProSciento Inc. ( Site 0002)
Chula Vista, California, United States
QPS-MRA, LLC ( Site 0003)
South Miami, Florida, United States
Bio-Kinetic Clinical Applications, LLD dba QPS-MO ( Site 0004)
Springfield, Missouri, United States
Hassman Research Institute Marlton Site ( Site 0006)
Marlton, New Jersey, United States
Start Date
March 4, 2026
Primary Completion Date
August 19, 2026
Completion Date
August 19, 2026
Last Updated
April 23, 2026
NCT00104325
NCT05447416
NCT03878121
NCT07090785
NCT01399385
NCT07526506
Lead Sponsor
Merck Sharp & Dohme LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions